chr19-1397365-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
This summary comes from the ClinGen Evidence Repository: The NM_000156.6:c.705A>T variant in GAMT is a missense variant that is predicted to cause the substitution of a lysine by an asparagine at amino acid position 235 (p.Lys235Asn). To our knowledge, this variant has not been reported in the literature and results of functional studies are unavailable. The highest population minor allele frequency in gnomAD v4.1.0. is 0.0004016 (18/44822 alleles) in the East Asian population (none of the population data codes are met). The computational predictor REVEL gives a score of 0.342 which is neither above nor below the thresholds predicting a damaging (>0.644) or benign (<0.29) impact on GAMT function. There is a ClinVar entry for this variant (Variation ID: 2137773). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for GAMT deficiency. GAMT-specific ACMG/AMP codes met, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes VCEP (Specifications Version 2.0.0): no criteria met.(Classification approved by the ClinGen Creatine Deficiency Syndromes Variant Curation Expert Panel on September 11, 2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA9043527/MONDO:0012999/026
Frequency
Consequence
ENST00000252288.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAMT | NM_000156.6 | c.705A>T | p.Lys235Asn | missense_variant | 6/6 | ENST00000252288.8 | NP_000147.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAMT | ENST00000252288.8 | c.705A>T | p.Lys235Asn | missense_variant | 6/6 | 1 | NM_000156.6 | ENSP00000252288.1 | ||
GAMT | ENST00000640762.1 | c.636A>T | p.Lys212Asn | missense_variant | 6/6 | 5 | ENSP00000492031.1 | |||
GAMT | ENST00000640164.1 | n.*18A>T | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000571 AC: 14AN: 245328Hom.: 0 AF XY: 0.0000599 AC XY: 8AN XY: 133458
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1459158Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 725914
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74422
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.705A>T (p.K235N) alteration is located in exon 6 (coding exon 6) of the GAMT gene. This alteration results from a A to T substitution at nucleotide position 705, causing the lysine (K) at amino acid position 235 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Cerebral creatine deficiency syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at